Nasdaq:US$16.36 (-0.09) | HKEX:HK$26.00 (-0.10) | AIM:£2.66 (-0.05)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF